Feedback
Expanded Carrier Screening Panel Targeted Mutation, 100-Plus Disorders with Fragile X
2007531
Ordering Recommendation

Preconception and prenatal carrier screening. Refer to "Additional Technical Information" document for disorders tested.

Mnemonic
ECS PANFGX
Methodology
Polymerase Chain Reaction
Performed
Varies
Reported
Within 14 days
New York DOH Approval Status
This test is New York DOH approved.
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Lavender EDTA. 
Specimen Preparation
Transport 4 mL whole blood. (Min: 1 mL) 
Storage/Transport Temperature
Room temperature. 
Unacceptable Conditions
 
Remarks
 
Stability
Ambient: 7 days; Refrigerated: 7 days; Frozen: Unacceptable 
Reference Interval
By report
Interpretive Data
Refer to report.

Note
CPT Code(s)
81200; 81205; 81209; 81220; 81242; 81250; 81251; 81255; 81260; 81290; 81330; 81332; 81400; 81401; 81479; 81243
Components
Component Test Code*Component Chart NameLOINC
2007532EER Expand Carrier SCRN, 100+DIS W/ FRGX11526-1
2008693Expanded Carrier SCRN, 100+W/FRAGX11526-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases

Performed at Counsyl